Recent News

• 03.03.2025 - 23andMe Special Committee Rejects Acquisition Proposal From CEO Anne Wojcicki
• 03.03.2025 - 23andMe Special Committee Rejects Acquisition Proposal From CEO Anne Wojcicki
• 01.31.2025 - 23andMe Launches New Genetic Report on Osteoporosis
• 01.31.2025 - 23andMe Launches New Genetic Report on Osteoporosis
• 01.28.2025 - 23andMe Special Committee Announces Exploration of Strategic Alternatives
• 01.28.2025 - 23andMe Special Committee Announces Exploration of Strategic Alternatives
• 01.28.2025 - 23andMe Special Committee Announces Exploration of Strategic Alternatives
• 01.28.2025 - 23andMe Special Committee Announces Exploration of Strategic Alternatives
• 01.28.2025 - 23andMe Reports Third Quarter Fiscal Year 2025 Financial Results
• 01.28.2025 - 23andMe Reports Third Quarter Fiscal Year 2025 Financial Results

Recent Filings

• 03.03.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 02.24.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.21.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 02.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 01.31.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 01.28.2025 - 8-K Current report